학술논문
SO-2 Quantitative risk-benefit assessment of ivosidenib compared to placebo in patients with IDH1-mutated intrahepatic cholangiocarcinoma: Phase 3 ClarIDHy trial
Document Type
Abstract
Author
Source
In Annals of Oncology June 2023 34 Supplement 1:S162-S162
Subject
Language
ISSN
0923-7534